Patient Leaflet Updated 04-Jul-2024 | Glenmark Pharmaceuticals Europe Ltd
Montelukast 10 mg Film-coated Tablets
Montelukast 10 mg Film-coated Tablets
montelukast
1. What Montelukast 10 mg Film-coated Tablets is and what it is used for
2. What you need to know before you take Montelukast 10 mg Film-coated Tablets
3. How to take Montelukast 10 mg Film-coated Tablets
4. Possible side effects
5. How to store Montelukast 10 mg Film-coated Tablets
6. Contents of the pack and other information
Montelukast 10 mg Film-coated Tablets is a leukotriene receptor antagonist that blocks the substance called leukotrienes. Leukotrienes can cause the narrowing and swelling of airways in your lungs and also cause allergy symptoms. By blocking leukotrienes, this medicine improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis).
Your doctor has prescribed Montelukast 10 mg Film-coated Tablets to treat asthma, preventing your asthma symptoms during the day and night.
Your doctor will determine how this medicine should be used depending on the symptoms and severity of your asthma.
Asthma is a long-term disease.
Asthma includes:
Symptoms of asthma include: coughing, wheezing, and chest tightness.
Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are an allergic response often caused by airborne pollen from trees, grass and weeds. The symptoms of seasonal allergies typically may include stuffy, runny, itchy nose; sneezing; watery, swollen, red and itchy eyes.
Tell your doctor about any medical problems or allergies you have now or previously had.
If you are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).
Talk to your doctor or pharmacist before taking this medicine.
Montelukast should not be used in place of other asthma medications your doctor has prescribed for you.
Various neuropsychiatric events (for example behaviour and mood-related changes, depression and suicidality) have been reported in patients of all ages treated with montelukast (see section 4). If you develop such symptoms while taking montelukast, you should contact your doctor.
Do not give this medicine to children less than 15 years of age.
For children from the age of 2 to 5 years old, Montelukast 4 mg Chewable Tablets are available.
For children from the age of 6 to 14 years old, Montelukast 5 mg Chewable Tablets are available.
For children 6 months to 5 years 4mg granules are also available.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those medicines obtained without a prescription. This includes medicines, herbal remedies, health products or supplements that you have obtained without a prescription.
Treatment with Montelukast 10 mg Film-coated Tablets can be affected by other medicines. Some medicines may affect how montelukast works, or montelukast may affect how other medicines work.
Tell your doctor if you are taking any of the following medicines before starting Montelukast 10 mg
Film-coated Tablets:
Phenobarbital (used for treatment of epilepsy)
Phenytoin (used for treatment of epilepsy)
Rifampicin (used to treat tuberculosis and some other infections)
Gemfibrozil (used for treatment of high lipid levels in plasma).
Ask your doctor or pharmacist for advice before taking any medicine.
Pregnancy
Women who are pregnant or intend to become pregnant should consult their doctor before taking this medicine. Your doctor will assess whether you can take this medicine during this time.
Breast-feeding
It is not known if this medicine appears in breast milk. You should consult your doctor before taking this medicine if you are breast feeding or intend to breast-feed.
This medicine is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported with this medicine may affect some patients ability to drive or operate machinery, therefore caution is advised.
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars (rare hereditary problems, galactose intolerance, the lapp lactose deficiency of glucose-galactose malabsorption), you should contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one 10 mg tablet to be taken daily in the evening. This medicine may be taken with or without food.
If you are taking this medicine, be sure that you do not take any other products that contain the same active ingredient, montelukast.
If you take more tablets than you should contact your doctor immediately for advice.
There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and adolescents included abdominal pain, sleepiness, thirst, headache, vomiting and hyperactivity (unusually active).
Try to take this medicine as recommended to you by your doctor. However, if you miss a dose, just take your tablet as soon as you remember. Take your next dose of one tablet once daily at the usual time. Do not take a double dose to make up for a forgotten tablet.
This medicine can treat your asthma only if you continue to take it. It is important to continue taking this medicine as prescribed to you by your doctor. It will help control your asthma.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In clinical studies with Montelukast 10 mg film-coated tablets, the most commonly reported side effects (may affect up to 1 in 10 people) thought to be related to this medicine were:
These were usually mild and occurred at a greater frequency in patients treated with montelukast than placebo (a pill containing no medication).
Serious side effects
Talk with your doctor immediately if you notice any of the following side effects, which may be serious, and for which you may need urgent medical treatment.
Uncommon: the following may affect up to 1 in 100 people
Rare: the following may affect up to 1 in 1,000 people
Very rare: the following may affect up to 1 in 10,000 people
Additionally, while the medicine has been on the market, the following have been reported:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Behaviour and mood related changes, such as:
Rare side effects (may affect up to than 1 in 1,000 people):
Very rare side effects (may affect up to 1 in 10,000 people):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
HDPE container:
Use within 30 days of opening. Once the pack has been opened write the date of opening on the space provided on the package label and also write the date by when the product should be used.
Store the medicine in the original package to protect from moisture. This medicinal product does not require any special temperature storage conditions.
Aluminium/aluminium blisters:
Store in the original package to protect from moisture. Do not store above 30°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Core:
Cellulose microcrystalline
Lactose monohydrate
Croscarmellose sodium
Hydroxypropylcellulose (E463)
Magnesium stearate
Film-coating:
Hypromellose (E464)
Hydroxypropylcellulose (E463)
Titanium dioxide (E171)
Iron Oxide yellow (E172)
Carnauba wax (E903)
Iron Oxide red (E172)
10 mg tablets are beige, round, 8 mm biconvex, film-coated tablets, engraved with ‘G’ on one side and ‘392’on the other side.
Montelukast 10 mg Film-coated Tablets are available in Aluminium/Aluminium blister pack or HDPE containers in cardboard carton with polypropylene child resistant closure and silica gel desiccant canister.
Pack sizes: 20, 28, 30, 50 and 100.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
This leaflet was last revised in 07/2024
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950